Bumped kinase inhibitor compositions and methods for treating cancer
US10350211B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2016 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | Jan 26, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is generally directed to bumped kinase inhibitor (BKI) compositions and methods for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.